Get the Stockscreener App
0.972
1.82%
-0.018
After Hours:
.99
0.018
+1.85%
Microbot Medical Inc stock is traded at $0.972, with a volume of 115.34K.
It is down -1.82% in the last 24 hours and down -0.49% over the past month.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
See More
Previous Close:
$0.99
Open:
$0.99
24h Volume:
115.34K
Relative Volume:
0.75
Market Cap:
$16.93M
Revenue:
-
Net Income/Loss:
$-10.58M
P/E Ratio:
-0.6568
EPS:
-1.48
Net Cash Flow:
$-9.21M
1W Performance:
+5.65%
1M Performance:
-0.49%
6M Performance:
-4.71%
1Y Performance:
-28.53%
1-Day Range:
$0.9631
$1.02
1-Week Range:
$0.89
$1.03
52-Week Range:
$0.82
$2.3499
Microbot Medical Inc Stock (MBOT) Company Profile
Name
Microbot Medical Inc
Sector
Industry
Phone
908-938-5561
Address
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
0.972 | 16.93M | 0 | -10.58M | -9.21M | -1.48 |
|
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-24-19 | Reiterated | H.C. Wainwright | Buy |
| Jan-31-18 | Initiated | Ladenburg Thalmann | Buy |
Microbot Medical Inc Stock (MBOT) Latest News
MBOT (Microbot Medical) EPS without NRI : $-0.80 (TTM As of Sep. 2024) - GuruFocus.com
Microbot Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Microbot Medical (MBOT) Stock Price, News & Analysis - MarketBeat
Microbot Medical’s Liberty Robot Study Draws to a Close - MPO-mag
Microbot Medical Releases Investor Presentation Materials - TipRanks
Yoav Zvi Waizer Net Worth (2024) - GuruFocus.com
Microbot Medical LIBERTY System Trial Advancing Faster Than Expected - MPO-mag
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 - MSN
Microbot Medical Stock Rises After Completing ACCESS-PVI Trial - Yahoo Finance
Market Update: Microbot Medical Inc (MBOT) Sees Positive Movement, Closing at 0.96 - The Dwinnex
Microbot Medical completes key clinical trial, eyes FDA submission By Investing.com - Investing.com Australia
CMR Surgical wins FDA nod for surgical robot Versius - Medical Device Network
Microbot eyes FDA application for surgical robot after completing pivotal trial - Medical Device Network
Microbot Medical completes enrolment for ACCESS-PVI clinical trial - Vascular News
Microbot Medical completes key clinical trial, eyes FDA submission - Investing.com
Microbot Medical Advances Towards FDA Submission and Market Entry - TipRanks
Microbot Medical Announces the Successful Completion of its - GlobeNewswire
Microbot Medical faces Nasdaq delisting over share price - Investing.com India
Microbot Medical faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa
Microbot Medical nears end of pivotal clinical trial - Investing.com
Microbot shifts pivotal trial up a gear with completion expected ahead of schedule - Medical Device Network
Microbot Medical Nears FDA Submission with Clinical Advances - TipRanks
Microbot Medical Inc. Accelerates Patient Enrollment of Its Pivotal Human Clinical Trial - Marketscreener.com
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to - The Bakersfield Californian
Microbot Medical Accelerates Patient Enrollment of its - GlobeNewswire
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up - StockTitan
Epoch Investment Partners Inc. Decreases Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat
MicroAlgo receives Nasdaq minimum bid price warning - Investing.com
MicroAlgo Faces Nasdaq Minimum Price Warning - TipRanks
MLGO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Quarterly Snapshot: Quick and Current Ratios for MicroAlgo Inc (MLGO) - The Dwinnex
The Wild Robot giveaway - Lyles Movie Files
Pedro Pascal and Lupita Nyong’o starrer The Wild Robot to release in Indian theatres on October 18 - Bollywood Hungama
Win Advance Screening Passes to THE WILD ROBOT in Florida - FlickDirect, Your Premiere Source For Movies And Entertainment!
Creo Medical Partners with Micro-Tech for Strategic Growth - TipRanks
Microbot Medical (NASDAQ:MBOT) & Treace Medical Concepts (NASDAQ:TMCI) Head-To-Head Review - Defense World
OrbiMed executives purchase $12 million of MBX Biosciences stock By Investing.com - Investing.com UK
The Wild Robot- Chicago – Advance Screening - The Movie Blog
Microbot Medical Advances in Endovascular Robotic Trials - TipRanks
Microbot Medical Announces the Successful Enrollment of 50% - GlobeNewswire
Microbot Medical Inc. Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System - Marketscreener.com
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System - Yahoo Finance
Microbot Medical Stock Is Moving Higher: What's Going On? - MSN
Microbot Medical Shares Investor Presentation Update - TipRanks
Trial Enrollment For LIBERTY Robotic Surgical System Reaches Midpoint - MPO-mag
MBOT stock touches 52-week low at $0.85 amid market challenges - Investing.com
Market Resilience: Microbot Medical Inc (MBOT) Finishes Weak at 0.88, Down -4.35 - The Dwinnex
THINK Surgical scoops additional FDA 510(k) clearance on Tmini surgical robot - Medical Device Network
Microbot Medical, Emory University To Consider LIBERTY Robotic System Partnership - MPO-mag
Microbot Medical advances Liberty Robotic System telesurgery innovation - Yahoo Finance
Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY - MSN
Microbot Medical Inc Stock (MBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):